Published in Infect Immun on November 10, 2014
The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway. Am J Respir Crit Care Med (2015) 1.45
In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa. Antimicrob Agents Chemother (2015) 0.76
The Salivary Microbiome and Oral Cancer Risk: A Pilot Study in Fanconi Anemia. J Dent Res (2016) 0.75
Outer Membrane Proteome of Veillonella parvula: A Diderm Firmicute of the Human Microbiome. Front Microbiol (2017) 0.75
A low-viscosity epoxy resin embedding medium for electron microscopy. J Ultrastruct Res (1969) 75.26
Differential expression analysis for sequence count data. Genome Biol (2010) 64.56
Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res (2010) 9.55
Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20
The human oral microbiome. J Bacteriol (2010) 9.00
An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A (2006) 7.62
Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry (1993) 7.53
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med (2008) 3.91
characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2004) 3.28
Systems-level analysis of microbial community organization through combinatorial labeling and spectral imaging. Proc Natl Acad Sci U S A (2011) 3.11
Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol (2003) 3.09
Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol (2006) 2.14
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Osteomyelitis due to Veillonella parvula: case report and review. Clin Infect Dis (1992) 1.86
Coaggregation properties of human oral Veillonella spp.: relationship to colonization site and oral ecology. Appl Environ Microbiol (1988) 1.67
The Pseudomonas aeruginosa transcriptome in planktonic cultures and static biofilms using RNA sequencing. PLoS One (2012) 1.65
Use of a simplified cell blot technique and 16S rRNA-directed probes for identification of common environmental isolates. Appl Environ Microbiol (1993) 1.60
Fluorescence in situ hybridization shows spatial distribution of as yet uncultured treponemes in biopsies from digital dermatitis lesions. Microbiology (1998) 1.55
Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations. PLoS One (2013) 1.43
The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication. Microbiology (2005) 1.43
Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res (2008) 1.42
Fluorescence in situ hybridization (FISH) for direct visualization of bacteria in periapical lesions of asymptomatic root-filled teeth. Microbiology (2003) 1.41
Analysis of a marine phototrophic biofilm by confocal laser scanning microscopy using the new image quantification software PHLIP. BMC Ecol (2006) 1.37
Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect (2009) 1.27
Salmonella-allies in the fight against cancer. J Mol Med (Berl) (2010) 1.24
Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol (2008) 1.22
Two fatal cases of Veillonella bacteremia. Eur J Clin Microbiol Infect Dis (1998) 1.22
Prosthetic joint infection due to Veillonella dispar. Eur J Clin Microbiol Infect Dis (2001) 1.15
Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling. J Clin Microbiol (2009) 1.13
Veillonella parvula discitis and secondary bacteremia: a rare infection complicating endoscopy and colonoscopy? J Clin Microbiol (2006) 1.11
Fluorescence in situ hybridization to improve the diagnosis of endocarditis: a pilot study. Clin Microbiol Infect (2009) 1.09
A 96-well-plate-based optical method for the quantitative and qualitative evaluation of Pseudomonas aeruginosa biofilm formation and its application to susceptibility testing. Nat Protoc (2010) 1.07
Was isolation of Veillonella from spinal osteomyelitis possible due to poor tissue perfusion? Med Hypotheses (2004) 1.05
Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis. Thorax (2010) 1.03
Veillonella parvula meningitis: case report and review of Veillonella infections. Clin Infect Dis (2000) 1.01
Prosthetic valve endocarditis caused by Veillonella parvula. J Infect (2005) 1.00
Approach to analyze interactions of microorganisms, hydrophobic substrates, and soil colloids leading to formation of composite biofilms, and to study initial events in microbiogeological processes. Methods Enzymol (2001) 0.93
Sepsis caused by Veillonella parvula infection in a 17-year-old patient with X-linked agammaglobulinemia (Bruton's disease). J Clin Microbiol (2006) 0.92
Ex vivo transcriptional profiling reveals a common set of genes important for the adaptation of Pseudomonas aeruginosa to chronically infected host sites. Environ Microbiol (2012) 0.91
Veillonella infections in children. J Clin Microbiol (1996) 0.90
Diversity of Veillonella spp. from sound and carious sites in children. J Dent Res (2008) 0.89
Effect of Veillonella parvula on the antimicrobial resistance and gene expression of Streptococcus mutans grown in a dual-species biofilm. Oral Microbiol Immunol (2008) 0.89
Bilateral abscessed orchiepididymitis associated with sepsis caused by Veillonella parvula and Clostridium perfringens: case report and review of the literature. J Clin Microbiol (1987) 0.89
Veillonella parvula bacteremia without an underlying source. J Clin Microbiol (1996) 0.86
Nosocomial infections in leukemic and solid-tumor cancer patients: distribution, outcome and microbial spectrum of anaerobes. Future Microbiol (2012) 0.85
Deep neck infections in children. J Microbiol Immunol Infect (2001) 0.84
Microstructural differences between single-species and dual-species biofilms of Streptococcus mutans and Veillonella parvula, before and after exposure to chlorhexidine. FEMS Microbiol Lett (2007) 0.80
Murine solid tumours as a novel model to study bacterial biofilm formation in vivo. J Intern Med (2014) 0.79
Anaerobic bacteria in cystic fibrosis: pathogens or harmless commensals? Thorax (2011) 0.79
Anaerobic bacteria colonizing the lower airways in lung cancer patients. Folia Histochem Cytobiol (2011) 0.79
Biofilm formation by Pseudomonas aeruginosa in solid murine tumors - a novel model system. Microbes Infect (2012) 0.79
Veillonella as a cause of chronic anaerobic pneumonitis. Int J Infect Dis (2008) 0.78
Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon Beta producers that protect from lethal encephalitis. J Virol (2014) 0.82
M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells. J Virol (2014) 0.78
RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury. Sci Transl Med (2017) 0.76
In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa. Antimicrob Agents Chemother (2015) 0.76
Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms. Int J Nanomedicine (2015) 0.75
Reaction-diffusion theory explains hypoxia and heterogeneous growth within microbial biofilms associated with chronic infections. NPJ Biofilms Microbiomes (2016) 0.75
A Novel Mouse Model of Staphylococcus aureus Vascular Graft Infection: Noninvasive Imaging of Biofilm Development in Vivo. Am J Pathol (2017) 0.75